Stock Idea: $MDGL (8 Feb 2023)
$MDGL
- Big 300% move after successful trials for company's liver disease drug
- Been consolidating. Failed to breakout in Jan from tight range
- Inside-day bar on Tue, coming after bullish reversal candle on Mon. Potential early entry
- Big 300% move after successful trials for company's liver disease drug
- Been consolidating. Failed to breakout in Jan from tight range
- Inside-day bar on Tue, coming after bullish reversal candle on Mon. Potential early entry